Mr. Speaker, I would like to thank my colleague from Brampton South for her leadership on this very important file.
Members will be interested to learn that last week I was pleased to announce a historic $200-million investment in Mississauga’s Resilience Biotechnologies to help increase manufacturing capacity for a range of vaccines, including those that use the mRNA technologies. This is yet another important step to support Canadian leadership in this vital sector and will help grow our life sciences ecosystem as an engine for economic recovery.